The Effect of Web-based Mindfulness-based Stress Reduction Program on Pregnant Women
Overview
Pregnancy is a period in which physiological and psychological changes are experienced and discomforts related to these changes are observed, and comfort is affected for the pregnant. However, fetal health concern refers to the concern of the expectant mother about the health of her developing fetus. Mindfulness is a non-judgmental and accepting focus of one's attention on what is happening right now. A total of 88 pregnant women (44 experimental, 44 control) are planned to be included in the study. Data will be collected with the "Personal Description Form", "Prenatal Comfort Scale (PCS)" and "Fetal Health Anxiety Inventory (FHAI)". In the study, a stress reduction program (MBSR) based on mindfulness will be applied by the researcher to the pregnant women in the experimental group.
Full Title of Study: “The Effect of Web-based Mindfulness-Based Stress Reduction Program on Prenatal Comfort and Fetal Anxiety Levels in Pregnants”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Supportive Care
- Masking: None (Open Label)
- Study Primary Completion Date: October 1, 2022
Detailed Description
Women experience intense physiological, psychological and social changes during pregnancy and postpartum period. Pregnancy and postpartum period can be a difficult process for some women due to biological and environmental factors. Mindfulness-based approaches have been used in solving both physical and mental problems in pregnant women and very positive results have been obtained. The aim of this study, which is carried out to determine the effect of mindfulness on prenatal comfort and fetal anxiety levels in pregnant women, is aimed at creating intervention programs compatible with the antenatal period and contributing to the improvement of pregnancy outcomes. A total of 88 pregnant women (44 experimental, 44 control) are planned to be included in the study. Data will be collected with the "Personal Description Form", "Prenatal Comfort Scale (PCS)" and "Fetal Health Anxiety Inventory (FHAI)". In the study, a stress reduction program (MBSR) based on mindfulness will be applied by the researcher to the pregnant women in the
Interventions
- Behavioral: Mindfullness Based Stress Reduction (MBSR) intervention
- Mindfullness Based Stress Reduction (MBSR) intervention: Monitoring stress and anxiety levels with mindfulness program
Arms, Groups and Cohorts
- Experimental: Mindfullness Based Stress Reduction
- Mindfullness Based Stress Reduction (MBSR) therapy
- No Intervention: Control
- Control
Clinical Trial Outcome Measures
Primary Measures
- Prenatal Comfort Scale
- Time Frame: At the end of the 2 months
- The minimum score that can be obtained from the scale is “0”, the maximum score is “75”, and as the score obtained from the scale increases, prenatal comfort levels also increase.
- Fetal Health Anxiety Inventory
- Time Frame: At the end of the 2 months
- The minimum score that can be obtained from the scale is “0”, the maximum score is “42”, and as the score obtained from the scale increases, fetal health anxiety levels also increase.
Participating in This Clinical Trial
Inclusion Criteria
- Not having any diagnosed psychiatric disease, – Literate, – Using a smart phone, – With internet access – Having a headset accessory for phone calls, – Pregnant women who voluntarily agreed to participate in the study Exclusion Criteria:
- Filling in the questionnaire form incompletely, – Pregnant women with communication barriers and mental disabilities
Gender Eligibility: Female
Pregnant
Minimum Age: 15 Years
Maximum Age: 40 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Amasya University
- Provider of Information About this Clinical Study
- Principal Investigator: Emine Akca, Assist. Prof. Dr. in the Amasya University Midwifery Department – Amasya University
- Overall Contact(s)
- Emine İbici Akça, 0 358 211 50 05, emineeibici@gmail.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.